RecruitingNCT06054451

Clinical Diagnosis and Pathological Spectrum of Porto-sinusoidal Vascular Disease in India


Sponsor

Post Graduate Institute of Medical Education and Research, Chandigarh

Enrollment

210 participants

Start Date

Aug 1, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

There is a need to re-evaluate the patients classified as NCPH and determine whether the new histological classification proposed by the VALDIG applies to the Indian scenario. We intend to identify the patient cohorts who have been diagnosed as NCPH, NCPF, EHPVO, hepatic venous outlet tract obstruction (HVOTO), Veno-occlusive disease (VOD) and sinusoidal obstruction syndrome (SOS) based on their liver biopsy, endoscopy, HVPG, and radiology reports. These patients will be screened to find the patients who fit the diagnosis of PSVD. It is important to establish whether the new definition of PSVD is relevant to the Indian population and establish the usefulness of invasive tests like liver biopsy in diagnosing the disease. The patient cohorts meeting diagnosis of INCPH will be compared with those meeting the new diagnosis of PSVD. The investigators will describe the clinical (demographic, clinical risk factors, socioeconomic status), etiological (associated conditions, coagulation disorders medication use, genetic risk factors), imaging (based on ultrasound Doppler imaging or cross- sectional imaging), endoscopic, fibrosis tests (using non-invasive tests), and the histopathology of the patients who fulfil the criteria of PSVD.


Eligibility

Min Age: 12 YearsMax Age: 70 Years

Plain Language Summary

Simplified for easier understanding

This study is examining the causes and patterns of a liver condition called porto-sinusoidal vascular disease (PSVD), which affects the blood vessels in the liver and leads to high blood pressure in the portal vein without cirrhosis. **You may be eligible if...** - You are between 12 and 70 years old (any gender) - You have been diagnosed with non-cirrhotic portal hypertension (NCPH) based on clinical, imaging, or tissue biopsy results **You may NOT be eligible if...** - You have liver cirrhosis (confirmed by any diagnostic method) - You have an active cancer diagnosis Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Dr. Madhumita Premkumar

Sector-12, Chandigarh, India

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06054451


Related Trials